You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Imatinib and/or Bosutinib Intolerance

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Information of Ponatinib, Bosutinib, Imatinib, Dasatinib and

Completed
  • Leukemia
  • No Intervention
  • Cambridge, Massachusetts
    Takeda
Feb 28, 2023

Chronic Myeloid Leukemia, Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission, Chronic Myeloid Leukemia in Remission Trial

Recruiting
  • Chronic Myeloid Leukemia
  • +2 more
  • Imatinib Mesylate, Dasatinib, Nilotinib or Bosutinib Withdrawal
  • Imatinib Mesylate, Dasatinib, Nilotinib or Bosutinib Re-initiation
  • Houston, Texas
  • +3 more
Jan 25, 2022

Lymphoma, Mantle-Cell Trial in Shanghai (Zanubrutinib, Rituximab, Bendamustin)

Not yet recruiting
  • Lymphoma, Mantle-Cell
  • Shanghai, Shanghai, China
    Ruijin Hospital
Nov 14, 2023

Landscape and Real-life Treatment Outcomes in Hungary: Analysis

Completed
  • Chronic Myeloid Leukaemia
  • Budapest, Hungary
    Pfizer
Dec 15, 2022

Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Trial in Frankfurt (Imatinib, Ponatinib, Blinatumomab)

Recruiting
  • Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
  • Frankfurt, Germany
    Department of Medicine, Hematology and Oncology, Goethe Universi
Sep 24, 2023

Gastrointestinal Stromal Tumors Trial in Seoul (Paclitaxel)

Recruiting
  • Gastrointestinal Stromal Tumors
  • Seoul, Korea, Republic of
    Asan Medical Center
Dec 30, 2022

GIST Trial (Ripretinib, Sunitinib)

Not yet recruiting
  • GIST
  • (no location specified)
Feb 8, 2023

Heart Failure, Type 2 Diabetes, Glucose Intolerance Trial in Montreal (Eplerenone, Spironolactone)

Completed
  • Heart Failure
  • +2 more
  • Montreal, Quebec, Canada
    Montreal Heart Institute
Oct 5, 2022

Primary Biliary Cholangitis Trial in United States (Seladelpar 10 mg, Placebo)

Recruiting
  • Primary Biliary Cholangitis
  • Seladelpar 10 mg
  • Placebo
  • Chandler, Arizona
  • +3 more
Oct 2, 2023

Gastrointestinal Stromal Tumors Trial in Houston (Regorafenib)

Not yet recruiting
  • Gastrointestinal Stromal Tumors
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2023

Advanced, Refractory Cancer Trial in Seoul (Imatinib)

Active, not recruiting
  • Advanced, Refractory Cancer
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jun 13, 2022

Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive Trial in Worldwide (Imatinib, Nilotinib, Bosutinib)

Recruiting
  • Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
  • Longmont, Colorado
  • +128 more
Aug 1, 2022

Eosinophilic Myeloid Tumor, Hypereosinophilic Syndrome Trial run by the National Institute of Allergy and Infectious Diseases

Recruiting
  • Eosinophilic Myeloid Neoplasm
  • Hypereosinophilic Syndrome
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Generalized Anxiety Disorder Trial (Metacognitive Internet delivered Cognitive Behavior Therapy, Intolerance of uncertainty

Not yet recruiting
  • Generalized Anxiety Disorder
  • Metacognitive Internet delivered Cognitive Behavior Therapy
  • Intolerance of uncertainty based Internet delivered Cognitive Behavior Therapy
  • (no location specified)
Apr 27, 2023

Describe Real World Use of Bosutinib inSingle Centre in Scotland

Completed
  • Myeloid Leukemia
  • Glasgow, United Kingdom
    eatson West of Scotland Cancer Centre
May 3, 2022

Chronic Myeloid Leukemia (CML) Trial in Italy (Ponatinib 15mg QD, Ponatinib 30mg QD)

Not yet recruiting
  • Chronic Myeloid Leukemia (CML)
  • Ponatinib 15mg QD
  • Ponatinib 30mg QD
  • Cagliari, Italy
  • +12 more
Jan 31, 2021

ALK+ Anaplastic Large Cell Lymphoma Trial in Wien (Brentuximab vedotin, Imatinib)

Terminated
  • ALK+ Anaplastic Large Cell Lymphoma
  • Wien, Austria
    Universitätsklinik f. Innere Medizin I, AKH Wien, Klinische Abte
Feb 15, 2022

Breast Cancer Trial in United States (gemcitabine HCl, imatinib mesylate)

Terminated
Has Results
  • Breast Cancer
  • gemcitabine hydrochloride
  • imatinib mesylate
  • Chicago, Illinois
  • +8 more
Aug 12, 2022

Chronic Myeloid Leukemia, Chronic Phase, CML, Chronic Phase, CML, Refractory Trial in Worldwide (Radotinib HCl)

Recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
  • +3 more
  • Radotinib HCl
  • Uijeongbu-si, Gyeonggi-do, Korea, Republic of
  • +17 more
Jan 3, 2022

Chronic Myeloid Leukemia, Chronic Myeloid Leukemia in Remission, BCR-ABL Positive Chronic Myelogenous Leukemia Trial in Moscow

Active, not recruiting
  • Chronic Myeloid Leukemia
  • +2 more
  • Moscow, Russian Federation
    National Research Center for Hematology
Oct 1, 2020

Breast Cancer Trial in Worldwide (Bosutinib, Letrozole)

Terminated
Has Results
  • Breast Cancer
  • Whittier, California
  • +10 more
Aug 31, 2021

Chronic Myelomonocytic Leukemia, Chronic Myeloid Leukemia, Polycythemia Vera Trial in Houston (Imatinib Mesylate (Gleevec))

Completed
Has Results
  • Chronic Myelomonocytic Leukemia
  • +4 more
  • Imatinib Mesylate (Gleevec)
  • Houston, Texas
    UT MD Anderson Cancer Center
Dec 7, 2021

Recurrent or Metastatic Colorectal Cancer Trial (Nelmastobart and Capecitabine)

Not yet recruiting
  • Recurrent or Metastatic Colorectal Cancer
  • Nelmastobart and Capecitabine
  • (no location specified)
Aug 6, 2023

Liver Fibrosis Trial in Tehran (Imatinib 200mg, Placebo)

Active, not recruiting
  • Liver Fibrosis
  • Imatinib 200mg
  • Placebo
  • Tehran, Iran, Islamic Republic of
    Research Institute of Gastroenterology & Liver Diseases
Jan 24, 2022

Essential Thrombocythemia Trial (Bomedemstat, Anagrelide, Busulfan)

Not yet recruiting
  • Essential Thrombocythemia
  • (no location specified)
Oct 6, 2023